ソリリスの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

ソリリス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8％で37億3,490万米ドルに成長します。予測期間の成長は、補体介在性疾患の有病率の増加、遺伝子治療の進歩、新興地域における市場アクセスの拡大、バイオシミラーの拡大、患者のコンプライアンス向上に起因すると考えられます。予測期間における主要動向としては、併用療法の採用、患者中心の治療の増加、個別化医療へのシフト、デジタルヘルス技術の利用拡大、費用対効果と価値によるケアの重視などが挙げられます。

希少血液疾患の有病率の増加は、ソリリス市場の成長を促進すると予想されます。血友病、鎌状赤血球貧血、サラセミアなどの希少血液疾患は、血液の産生、成分、凝固に影響を及ぼす疾患です。これらの疾患の増加は、診断技術の向上、認知度の向上、遺伝的・環境的要因によるものです。ソリリス（エクリズマブ）は、補体タンパク質C5を阻害することにより、これらの疾患の管理に役立ち、補体の過剰な活性化を防ぎ、溶血や臓器障害などの重篤な合併症のリスクを低減します。NHSイングランドによると、約1万7,000人が鎌状赤血球症を患っており、年間250人が新たに鎌状赤血球症と診断されています。この有病率の増加がソリリスの需要を牽引しています。

希少疾患調査への投資の増大が、ソリリス市場に拍車をかけています。ゲノミクスの進歩とアンメットメディカルニーズの認識により、ソリリスで治療される疾患の理解を深める希少疾患調査への投資が増加しています。これは、効果的な治療に対する需要の増加につながります。例えば、2023年7月、英国政府はBiomedical Research Centersに8億3,420万米ドル、UK Rare Disease Research Platformに1,506万米ドルを含む多額の資金を投資しました。この投資は、希少疾患の診断と治療開拓を強化し、ソリリス市場の成長をさらに促進することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のソリリス：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のソリリス市場：成長率分析
• 世界のソリリス市場の実績：規模と成長、2019～2024年
• 世界のソリリス市場の予測：規模と成長、2024～2029年、2034年
• 世界のソリリス：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のソリリス市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血漿交換
• 血漿注入
• 世界のソリリス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 発作性夜間血色素尿症（PNH）
• 非典型溶血性尿毒症症候群（AHUS）
• 世界のソリリス市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のソリリス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のソリリス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• ソリリス市場：競合情勢
• ソリリス市場：企業プロファイル
  • Pfizer
  • SLR

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• ソリリス市場、2029年：新たな機会を提供する国
• ソリリス市場、2029年：新たな機会を提供するセグメント
• ソリリス市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Soliris (eculizumab) is a monoclonal antibody developed by Alexion Pharmaceuticals. It works by inhibiting the complement protein C5, thereby reducing inflammation and damage caused by an overactive immune system. Soliris is primarily used to treat rare diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of soliris are plasma exchange and plasma infusion. Plasma exchange is a medical procedure in which a patient's plasma is removed and replaced to treat various conditions, including autoimmune or blood disorders. It is used for treating conditions like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The soliris market research report is one of a series of new reports from The Business Research Company that provides soliris market statistics, including the soliris industry's global market size, regional shares, competitors with a soliris market share, detailed Soliris market segments, market trends and opportunities, and any further data you may need to thrive in the soliris industry. This soliris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The soliris market size is expected to see strong growth in the next few years. It will grow to $3,734.9 million in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to the increasing prevalence of complement-mediated diseases, advancements in gene therapy, growing market access in emerging regions, expansion of biosimilars, and improved patient compliance. Major trends in the forecast period include the adoption of combination therapies, rise in patient-centric treatments, shift towards personalized medicine, growing use of digital health technologies, and focus on cost-effectiveness and value-based care.

The increasing prevalence of rare blood disorders is expected to propel the growth of the soliris market. Rare blood disorders, such as hemophilia, sickle cell anemia, and thalassemia, are conditions that affect blood production, components, or clotting. The rise in these disorders is attributed to improved diagnostic techniques, greater awareness, and genetic and environmental factors. Soliris (eculizumab) helps manage these conditions by inhibiting the complement protein C5, which prevents excessive complement activation, reducing the risk of severe complications like hemolysis and organ damage. According to NHS England, approximately 17,000 people are living with sickle cell disease, with 250 new cases diagnosed annually. This increasing prevalence is driving the demand for soliris.

The growing investment in rare disease research is fueling the soliris market. With advancements in genomics and the recognition of unmet medical needs, there is increased investment in rare disease research, which helps expand the understanding of conditions treated by Soliris. This leads to a rise in demand for effective treatments. For instance, in July 2023, the UK government invested significant funds, including USD 834.20 million for Biomedical Research Centers and USD 15.06 million for the UK Rare Disease Research Platform. This investment aims to enhance diagnostic and treatment development for rare diseases, further promoting the growth of the Soliris market.

A key trend in the soliris market is the development of biologic medicines for treating neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that affects the central nervous system. This development improves treatment options for rare blood disorders. In October 2023, AstraZeneca received approval for Soliris from China's National Medical Products Administration (NMPA) for the treatment of adult NMOSD patients who are positive for anti-aquaporin-4 (AQP4) antibodies. Soliris is the first and only complement inhibitor approved for NMOSD treatment in China, marking a significant advancement in managing this debilitating condition.

The Key player operating in the soliris market is Pfizer

North America was the largest region in the Soliris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in soliris report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the soliris market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The soliris market consists of sales of soliris (eculizumab) 300 mg/30 mL vial, soliris (eculizumab) injection. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Soliris Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on soliris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for soliris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The soliris market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Plasma Exchange; Plasma Infusion
• 2) By Application: Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (AHUS)
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Pfizer
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Soliris Market Characteristics

3. Soliris Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Soliris Market Trends And Strategies

5. Soliris Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Soliris Growth Analysis And Strategic Analysis Framework

• 6.1. Global Soliris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Soliris Market Growth Rate Analysis
• 6.4. Global Soliris Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Soliris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Soliris Total Addressable Market (TAM)

7. Global Soliris Market Pricing Analysis & Forecasts

8. Soliris Market Segmentation

• 8.1. Global Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma Exchange
• Plasma Infusion
• 8.2. Global Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Atypical Hemolytic Uremic Syndrome (AHUS)
• 8.3. Global Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

9. Global Soliris Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Soliris Market Regional And Country Analysis

• 10.1. Global Soliris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Soliris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Soliris Market

• 11.1. Asia-Pacific Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Soliris Market

• 12.1. China Soliris Market Overview
• 12.2. China Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Soliris Market

• 13.1. India Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Soliris Market

• 14.1. Japan Soliris Market Overview
• 14.2. Japan Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Soliris Market

• 15.1. Australia Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Soliris Market

• 16.1. South Korea Soliris Market Overview
• 16.2. South Korea Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Soliris Market

• 17.1. Western Europe Soliris Market Overview
• 17.2. Western Europe Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Soliris Market

• 18.1. UK Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Soliris Market

• 19.1. Germany Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Soliris Market

• 20.1. France Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Soliris Market

• 21.1. Eastern Europe Soliris Market Overview
• 21.2. Eastern Europe Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Soliris Market

• 22.1. North America Soliris Market Overview
• 22.2. North America Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Soliris Market

• 23.1. USA Soliris Market Overview
• 23.2. USA Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Soliris Market

• 24.1. Canada Soliris Market Overview
• 24.2. Canada Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Soliris Market

• 25.1. South America Soliris Market Overview
• 25.2. South America Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Soliris Market

• 26.1. Middle East Soliris Market Overview
• 26.2. Middle East Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Soliris Market

• 27.1. Africa Soliris Market Overview
• 27.2. Africa Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Soliris Market Competitive Landscape And Company Profiles

• 28.1. Soliris Market Competitive Landscape
• 28.2. Soliris Market Company Profiles
  • 28.2.1. Pfizer Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. SLR Overview, Products and Services, Strategy and Financial Analysis

29. Global Soliris Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Soliris Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Soliris Market

32. Recent Developments In The Soliris Market

33. Soliris Market High Potential Countries, Segments and Strategies

• 33.1 Soliris Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Soliris Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Soliris Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer